Zobrazeno 1 - 10
of 256
pro vyhledávání: '"National Virus Reference Laboratory"'
Autor:
Áine O'Toole, Verity Hill, Oliver G. Pybus, Alexander Watts, Issac I. Bogoch, Kamran Khan, Jane P. Messina, The COVID-19 Genomics UK (COG-UK) consortium, Network for Genomic Surveillance in South Africa (NGS-SA), Brazil-UK CADDE Genomic Network, Houriiyah Tegally, Richard R. Lessells, Jennifer Giandhari, Sureshnee Pillay, Kefentse Arnold Tumedi, Gape Nyepetsi, Malebogo Kebabonye, Maitshwarelo Matsheka, Madisa Mine, Sima Tokajian, Hamad Hassan, Tamara Salloum, Georgi Merhi, Jad Koweyes, Jemma L. Geoghegan, Joep de Ligt, Xiaoyun Ren, Matthew Storey, Nikki E. Freed, Chitra Pattabiraman, Pramada Prasad, Anita S. Desai, Ravi Vasanthapuram, Thomas F. Schulz, Lars Steinbrück, Tanja Stadler, Swiss Viollier Sequencing Consortium, Antonio Parisi, Angelica Bianco, Darío García de Viedma, Sergio Buenestado-Serrano, Vítor Borges, Joana Isidro, Sílvia Duarte, João Paulo Gomes, Neta S. Zuckerman, Michal Mandelboim, Orna Mor, Torsten Seemann, Alicia Arnott, Jenny Draper, Mailie Gall, William Rawlinson, Ira Deveson, Sanmarié Schlebusch, Jamie McMahon, Lex Leong, Chuan Kok Lim, Maria Chironna, Daniela Loconsole, Antonin Bal, Laurence Josset, Edward Holmes, Kirsten St. George, Erica Lasek-Nesselquist, Reina S. Sikkema, Bas Oude Munnink, Marion Koopmans, Mia Brytting, V. Sudha rani, S. Pavani, Teemu Smura, Albert Heim, Satu Kurkela, Massab Umair, Muhammad Salman, Barbara Bartolini, Martina Rueca, Christian Drosten, Thorsten Wolff, Olin Silander, Dirk Eggink, Chantal Reusken, Harry Vennema, Aekyung Park, Christine Carrington, Nikita Sahadeo, Michael Carr, Gabo Gonzalez, SEARCH Alliance San Diego, National Virus Reference Laboratory, SeqCOVID-Spain, Danish Covid-19 Genome Consortium (DCGC), Communicable Diseases Genomic Network (CDGN), Dutch National SARS-CoV-2 surveillance program, Division of Emerging Infectious Diseases (KDCA), Tulio de Oliveira, Nuno Faria, Andrew Rambaut, Moritz U. G. Kraemer
Publikováno v:
Wellcome Open Research, Vol 6 (2021)
Late in 2020, two genetically-distinct clusters of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with mutations of biological concern were reported, one in the United Kingdom and one in South Africa. Using a combination of data from ro
Externí odkaz:
https://doaj.org/article/63672d265a40472ea7302adbef66d81f
Autor:
Áine O'Toole, Verity Hill, Oliver G. Pybus, Alexander Watts, Issac I. Bogoch, Kamran Khan, Jane P. Messina, The COVID-19 Genomics UK (COG-UK) consortium, Network for Genomic Surveillance in South Africa (NGS-SA), Brazil-UK CADDE Genomic Network, Houriiyah Tegally, Richard R. Lessells, Jennifer Giandhari, Sureshnee Pillay, Kefentse Arnold Tumedi, Gape Nyepetsi, Malebogo Kebabonye, Maitshwarelo Matsheka, Madisa Mine, Sima Tokajian, Hamad Hassan, Tamara Salloum, Georgi Merhi, Jad Koweyes, Jemma L. Geoghegan, Joep de Ligt, Xiaoyun Ren, Matthew Storey, Nikki E. Freed, Chitra Pattabiraman, Pramada Prasad, Anita S. Desai, Ravi Vasanthapuram, Thomas F. Schulz, Lars Steinbrück, Tanja Stadler, Swiss Viollier Sequencing Consortium, Antonio Parisi, Angelica Bianco, Darío García de Viedma, Sergio Buenestado-Serrano, Vítor Borges, Joana Isidro, Sílvia Duarte, João Paulo Gomes, Neta S. Zuckerman, Michal Mandelboim, Orna Mor, Torsten Seemann, Alicia Arnott, Jenny Draper, Mailie Gall, William Rawlinson, Ira Deveson, Sanmarié Schlebusch, Jamie McMahon, Lex Leong, Chuan Kok Lim, Maria Chironna, Daniela Loconsole, Antonin Bal, Laurence Josset, Edward Holmes, Kirsten St. George, Erica Lasek-Nesselquist, Reina S. Sikkema, Bas Oude Munnink, Marion Koopmans, Mia Brytting, V. Sudha rani, S. Pavani, Teemu Smura, Albert Heim, Satu Kurkela, Massab Umair, Muhammad Salman, Barbara Bartolini, Martina Rueca, Christian Drosten, Thorsten Wolff, Olin Silander, Dirk Eggink, Chantal Reusken, Harry Vennema, Aekyung Park, Christine Carrington, Nikita Sahadeo, Michael Carr, Gabo Gonzalez, SEARCH Alliance San Diego, National Virus Reference Laboratory, SeqCOVID-Spain, Danish Covid-19 Genome Consortium (DCGC), Communicable Diseases Genomic Network (CDGN), Dutch National SARS-CoV-2 surveillance program, Division of Emerging Infectious Diseases (KDCA), Tulio de Oliveira, Nuno Faria, Andrew Rambaut, Moritz U. G. Kraemer
Publikováno v:
Wellcome Open Research, Vol 6 (2021)
Late in 2020, two genetically-distinct clusters of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with mutations of biological concern were reported, one in the United Kingdom and one in South Africa. Using a combination of data from ro
Externí odkaz:
https://doaj.org/article/4d50ca9e659b4b69b1e58f7d34df6deb
Autor:
SONIA PEREZ CASTRO, Amparo Larrauri, Catherine Moore, Sylvie Van der WERF, Nuria Torner, Pedro Pechirra, FALCHI Alessandra, Bruno Lina, Lisa Domegan, Cathriona Kearns, Thea Kølsen Fischer, Maria Concepcion Delgado Sanz, Francisco Pozo, Simon De Lusignan, Lidia Brydak, Santiago Melón García, Ramona Trebbien, Inmaculada Casas, Richard Pebody, Silvia Jiménez-Jorge
Publikováno v:
Eurosurveillance
Eurosurveillance, 2018, 23 (5), ⟨10.2807/1560-7917.ES.2018.23.5.17-00284⟩
Eurosurveillance, 2018, 23 (5), ⟨10.2807/1560-7917.ES.2018.23.5.17-00284⟩
Respiratory syncytial virus (RSV) is considered the major pathogen causing severe lower respiratory tract infections among infants and young children [1]. RSV is the most common cause of hospitalisation for acute lower respiratory tract infection in
Autor:
Pereyaslov, D., Rosin, P., Palm, D., Zeller, H., Gross, D., Brown, C. S., Struelens, M. J., Robo, A., Hatibi, I. H., Alis, J. C., Sargsyan, S., Gurbanov, S., Gribkova, N., Ranst, M., Ieven, G., Patteet, S., Tomic, S., Korsun, N., Drazenovic, V., Pieridou-Bagkatzouni, D., Jirincova, H., Havlickova, M., Fomsgaard, A., Rae, K., Lappalainen, M., Ikonen, N., Lina, B., Sylvie van der WERF, Manuguerra, J. -C, Machablishvili, A., Eickmann, M., Wolff, T., Dobler, G., Schmidt-Chanasit, J., Drosten, C., Papa, A., Mentis, A. F., Kis, Z., Löve, A., Coughlan, S., Mandelboim, M., Capobianchi, M. R., Landini, M. P., Baldanti, F., Palu, G., Ghisetti, V., Donatelli, I., Nusupbayeva, G., Tokhtabakiyeva, Z., Kasymbekova, K., Storozenko, J., Erne, S., Griskevicius, A., Opp, M., Barbara, C., Vratnica, Z., Reusken, C., Dudman, S. G., Hungnes, O., Pancer, K., Guiomar, R., Eder, V., Lupulescu, E., Yatsyshina, S., Pisareva, M., Buzitskaya, Z., Sergeev, A., Nedeljković, J., Staroňová, E., Županc, T. A., Petrovec, M., Korva, M., Prosenc, K., Casas, I., Gaines, H., Cherpillod, P., Zakirova, N., Bosevska, G., Altas, B., Ciblak, M., Mironenko, A., Dykhanovska, T., Demchyshyna, I., Bermingham, A., Rakhimov, R.
Publikováno v:
Eurosurveillance
Eurosurveillance, 2014, 19 (40), ⟨10.2807/1560-7917.es2014.19.40.20923⟩
Scopus-Elsevier
Eurosurveillance, 2014, 19 (40), ⟨10.2807/1560-7917.es2014.19.40.20923⟩
Scopus-Elsevier
Since September 2012, over 90 cases of respiratory disease caused by a novel coronavirus, now named Middle East respiratory syndrome coronavirus (MERS-CoV), have been reported in the Middle East and Europe. To ascertain the capabilities and testing e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42349787fdf1ae7793b466a08c934177
http://intor.torlakinstitut.com/handle/123456789/416
http://intor.torlakinstitut.com/handle/123456789/416
Publikováno v:
Retrovirology
Retrovirology, BioMed Central, 2012, 9 (1), pp.98. 〈10.1186/1742-4690-9-98〉
Retrovirology, Vol 9, Iss 1, p 98 (2012)
Retrovirology, BioMed Central, 2012, 9 (1), pp.98. 〈10.1186/1742-4690-9-98〉
Retrovirology, Vol 9, Iss 1, p 98 (2012)
Background In contrast with human T-cell leukemia virus type 1 (HTLV-1) that causes ATL (adult T-cell leukemia), HTLV-2 has not been causally linked to malignant disease. The minus strand of the HTLV genomes encode the regulatory proteins HTLV-1 bZIP
Autor:
Tabata K; Hokkaido University, Institute for Vaccine Research and Development (HU-IVReD), Sapporo, Hokkaido 001-0021, Japan., Kobayashi S; Hokkaido University, Institute for Vaccine Research and Development (HU-IVReD), Sapporo, Hokkaido 001-0021, Japan; Laboratory of Public Health, Department of Preventive Veterinary Medicine, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido 060‑0818, Japan., Itakura Y; Hokkaido University, Institute for Vaccine Research and Development (HU-IVReD), Sapporo, Hokkaido 001-0021, Japan., Gonzalez G; Hokkaido University, Institute for Vaccine Research and Development (HU-IVReD), Sapporo, Hokkaido 001-0021, Japan., Kabamba CF; Hokkaido University, Institute for Vaccine Research and Development (HU-IVReD), Sapporo, Hokkaido 001-0021, Japan., Saito S; Hokkaido University, Institute for Vaccine Research and Development (HU-IVReD), Sapporo, Hokkaido 001-0021, Japan., Sasaki M; Hokkaido University, Institute for Vaccine Research and Development (HU-IVReD), Sapporo, Hokkaido 001-0021, Japan; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido 001-0020, Japan., Hall WW; Hokkaido University, Institute for Vaccine Research and Development (HU-IVReD), Sapporo, Hokkaido 001-0021, Japan; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido 001-0020, Japan; Global Virus Network, Baltimore, MD 21201, USA; National Virus Reference Laboratory, University College Dublin, Belfield, Dublin 4, Ireland., Sawa H; Hokkaido University, Institute for Vaccine Research and Development (HU-IVReD), Sapporo, Hokkaido 001-0021, Japan; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido 001-0020, Japan; Global Virus Network, Baltimore, MD 21201, USA; One Health Research Center, Hokkaido University, Sapporo, Hokkaido 001-0020, Japan., Orba Y; Hokkaido University, Institute for Vaccine Research and Development (HU-IVReD), Sapporo, Hokkaido 001-0021, Japan; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido 001-0020, Japan; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido 001-0020, Japan; One Health Research Center, Hokkaido University, Sapporo, Hokkaido 001-0020, Japan. Electronic address: orbay@czc.hokudai.ac.jp.
Publikováno v:
Journal of virological methods [J Virol Methods] 2024 Sep; Vol. 329, pp. 115007. Date of Electronic Publication: 2024 Aug 16.
Autor:
Konishi K; Laboratory for Drug Discovery & Disease Research, Shionogi & Co., Ltd., Osaka, Japan; Division of Anti-Virus Drug Research, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan., Kusakabe S; Laboratory for Drug Discovery & Disease Research, Shionogi & Co., Ltd., Osaka, Japan; Division of Anti-Virus Drug Research, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan., Kawaguchi N; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan., Shishido T; Laboratory for Drug Discovery & Disease Research, Shionogi & Co., Ltd., Osaka, Japan., Ito N; Laboratory of Zoonotic Diseases, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan., Harada M; Department of Veterinary Science, National Institute of Infectious Diseases (NIID), Tokyo, Japan., Inoue S; Department of Veterinary Science, National Institute of Infectious Diseases (NIID), Tokyo, Japan., Maeda K; Department of Veterinary Science, National Institute of Infectious Diseases (NIID), Tokyo, Japan., Hall WW; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan; National Virus Reference Laboratory, School of Medicine, University College of Dublin, Ireland; Global Virus Network, Baltimore, MD, USA; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan., Orba Y; Division of Anti-Virus Drug Research, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan; One Health Research Center, Hokkaido University, Sapporo, Japan., Sawa H; Division of Anti-Virus Drug Research, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan; Global Virus Network, Baltimore, MD, USA; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan; One Health Research Center, Hokkaido University, Sapporo, Japan., Sasaki M; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan. Electronic address: m-sasaki@czc.hokudai.ac.jp., Sato A; Laboratory for Drug Discovery & Disease Research, Shionogi & Co., Ltd., Osaka, Japan; Division of Anti-Virus Drug Research, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan. Electronic address: akihiko.sato@shionogi.co.jp.
Publikováno v:
Antiviral research [Antiviral Res] 2024 Sep; Vol. 229, pp. 105977. Date of Electronic Publication: 2024 Jul 31.
Autor:
Kawaguchi N; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan., Itakura Y; Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Japan., Intaruck K; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan., Ariizumi T; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan., Harada M; Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan., Inoue S; Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan., Maeda K; Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan., Ito N; Laboratory of Zoonotic Diseases, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan., Hall WW; Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Japan.; National Virus Reference Laboratory, School of Medicine, University College of Dublin, Dublin, Ireland.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Global Virus Network, Baltimore, MD, USA., Sawa H; Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Japan.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Global Virus Network, Baltimore, MD, USA.; One Health Research Center, Hokkaido University, Sapporo, Japan., Orba Y; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Japan.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; One Health Research Center, Hokkaido University, Sapporo, Japan., Sasaki M; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan. m-sasaki@czc.hokudai.ac.jp.; Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Japan. m-sasaki@czc.hokudai.ac.jp.
Publikováno v:
Scientific reports [Sci Rep] 2024 Aug 09; Vol. 14 (1), pp. 18509. Date of Electronic Publication: 2024 Aug 09.
Autor:
Cui M; School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, People's Republic of China., Bi Y; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China., Guo M; Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China., Carr MJ; National Virus Reference Laboratory, School of Medicine, University College Dublin, Dublin, Ireland.; International Collaboration Unit, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan., Shi W; School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, People's Republic of China.; Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.; Shanghai Institute of Virology, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China., Ma Z; College of Life Science and Technology, Xinjiang University, Urumqi, People's Republic of China., Zhou H; School of Clinical and Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, People's Republic of China.; Key Laboratory of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, People's Republic of China.
Publikováno v:
Vector borne and zoonotic diseases (Larchmont, N.Y.) [Vector Borne Zoonotic Dis] 2024 Jul 27. Date of Electronic Publication: 2024 Jul 27.
Autor:
Laniece Delaunay C; Epiconcept, Paris, France., Melo A; National Reference Laboratory for Influenza Virus and Other Respiratory Visuses, Infectious disease department - National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal., Maurel M; Epiconcept, Paris, France., Mazagatos C; National Centre of Epidemiology, CIBERESP, Carlos III Health Institute, Madrid, Spain., Goerlitz L; Robert Koch institute, Berlin, Germany., O'Donnell J; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Oroszi B; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary., Sève N; Sorbonne Université, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France., Rodrigues AP; Epidemiology department, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal., Martínez-Baz I; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain., Meijer A; National Institute for Public Health and the Environment, Centre for Infectious Diseases Control, Bilthoven, the Netherlands., Mlinarić I; Croatian Institute of Public Health, Zagreb, Croatia., Latorre-Margalef N; Public Health Agency of Sweden, Stockholm, Sweden., Lazăr M; Cantacuzino National Military Medical Institute for Research and Development, Bucharest, Romania., Pérez-Gimeno G; National Centre of Epidemiology, CIBERESP, Carlos III Health Institute, Madrid, Spain., Dürrwald R; National Reference Centre for Influenza, Robert Koch Institute, Berlin, Germany., Bennett C; UCD-National Virus Reference Laboratory, University College Dublin, Dublin, Ireland., Túri G; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary., Rameix-Welti MA; Centre National de Référence Virus des Infections Respiratoire (CNR VIR), Institut Pasteur, Université Paris Cité, Paris, France; Institut Pasteur, Université Paris-Saclay, Université de Versailles St. Quentin, Université Paris Cité, UMR 1173 (2I), INSERM, Assistance Publique des Hôpitaux de Paris, Paris, France., Guiomar R; National Reference Laboratory for Influenza Virus and Other Respiratory Visuses, Infectious disease department - National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal., Castilla J; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain., Hooiveld M; Nivel, Utrecht, the Netherlands., Kurečić Filipović S; Croatian Institute of Public Health, Zagreb, Croatia., Samuelsson Hagey T; Public Health Agency of Sweden, Stockholm, Sweden., Dijkstra F; National Institute for Public Health and the Environment, Centre for Infectious Diseases Control, Bilthoven, the Netherlands., Borges V; Bioinformatics Unit, Infectious Diseases Department, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal., Ramos Marín V; Servicio de Epidemiología de la Consejería de Sanidad y Servicios Sociales de Ceuta, Ceuta, Spain., Bacci S; European Centre for Disease Prevention and Control, Stockholm, Sweden., Kaczmarek M; European Centre for Disease Prevention and Control, Stockholm, Sweden., Kissling E; Epiconcept, Paris, France. Electronic address: e.kissling@epiconcept.fr.
Publikováno v:
Vaccine [Vaccine] 2024 Jul 25; Vol. 42 (19), pp. 3931-3937. Date of Electronic Publication: 2024 Jun 04.